Ik. Pajeva et M. Wiese, QSAR AND MOLECULAR MODELING OF CATAMPHIPHILIC DRUGS ABLE TO MODULATE MULTIDRUG-RESISTANCE IN TUMORS, Quantitative structure-activity relationships, 16(1), 1997, pp. 1-10
The Free-Wilson approach was applied to two groups of catamphiphilic m
ultidrug resistance (MDR) modifiers using classical multiple linear re
gression (MLR) and genetic algorithms (GA) for feature selection. In t
he first group (17 thioxanthenes) the side chain length between the ri
ng system and tertiary nitrogen, the type of the tertiary nitrogen sub
stituent and the stereoisomery were found to be significant for anti-M
DR activity both by MLR and GA (r(2) = 0.803, predictive power Q(2) =
0.652). In the second data set (17 phenothiazines and related drugs) t
he ring system type, the stereoisomery, the side chain type, and the r
ing substituent kind in position two contributed significantly (r(2) =
0.938 and Q(2) = 0.908). The QSAR studies showed a thioxanthene ring
with a -CF3 substituent in position two, a piperazine moiety with a 4-
bond distance from the ring system and trans-isomery to be optimal for
MDR reversal. Based on these results molecular modeling of trans-(T)
and cis-flupentixol (C) was performed assuming that the 2 to 3-fold di
fference in MDR reversing activity of T compared to C might be related
to different preferable conformations in the membrane lipid environme
nt. Among all conformations generated by the SYBYL systematic search r
outine those comprising local energy minima were selected and optimize
d with semiempirical quantum chemistry methods. The optimized conforma
tions were compared with H-1-NMR analysis results on drug conformation
s in lipid environment, some of them corresponded excellently. The ele
ctrostatic and lipophilic fields of T and C were compared to identify
molecular properties related to the activity difference. The results d
emonstrated that T and C could have a different (mirrorlike) orientati
on entering the lipid bilayer by the ring system suggesting much bette
r fitting of T compared to C to the lipid ''MDR-reversal receptor''.